Antiepileptic Drug Selection According to Seizure Type in Adult Patients with Epilepsy

키워드

참고문헌 (52)

1. Brodie MJ, "Antiepileptic drug therapy the story so far", Seizure, 19, pp.650~655 (2010)
2. Scott LJ, "Lacosamide : a review in focal seizures in patients with epilepsy", Drugs, 75, pp.2143~2154 (2015)
3. Hoy SM, "Topiramate extended release : a review in epilepsy", CNS Drugs, 30, pp.559~566 (2016)
4. Fabris RR, "Drug-resistant focal epilepsy in women of childbearing age : reproduction and the effect of epilepsy surgery", Epilepsy Behav, 60, pp.17~20 (2016)
5. French JA, "Efficacy and tolerability of the new antiepileptic drugs, I : treatment of new-onset epilepsy : report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society", Epilepsia, 45, pp.401~409 (2004)
6. Appleton RE, "Diagnosis and management of the epilepsies in children : a summary of the partial update of the 2012NICE epilepsy guideline", Arch Dis Child, 97, pp.1073~1076 (2012)
7. Scottish Intercollegiate Guidelines Network, "SIGN 50: a guideline developer’s handbook" (2011), Scottish Intercollegiate Guidelines Network
8. Glauser T, "ILAE treatment guidelines : evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes", Epilepsia, 47, pp.1094~1120 (2006)
9. Korean Epilepsy Society, "Clinical guideline for antiepileptic drug treatment in patient with epilepsy" (2015), Korean Epilepsy Society
10. Davies JA, "Mechanisms of action of antiepileptic drugs", Seizure, 4, pp.267~271 (1995)
11. Zhu MM, "The pharmacogenomics of valproic acid", J Hum Genet, 62, pp.1009~1014 (2017)
12. Howard P, "Levetiracetam", J Pain Symptom Manage, 56, pp.645~649 (2018)
13. Johannessen SI, "Pharmacokinetic variability of newer antiepileptic drugs : when is monitoring needed?", Clin Pharmacokinet, 45, pp.1061~1075 (2006)
14. Fisher RS, "Instruction manual for the ILAE 2017 operational classification of seizure types", Epilepsia, 58, pp.531~542 (2017)
15. Maiti R, "Effect of carbamazepine and oxcarbazepine on serum neuron-specific enolase in focal seizures : a randomized controlled trial", Epilepsy Res, 138, pp.5~10 (2017)
16. Marson AG, "The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial", Lancet, 369, pp.1000~1015 (2007)
17. Byun JI, "Treatment of epilepsy in adults : expert opinion in South Korea", Epilepsy Behav, 105, pp.106942~ (2020)
18. Marson AG, "A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs", Health Technol Assess, 11(37) (2007)
19. Cereghino JJ, "Levetiracetam for partial seizures : results of a double-blind, randomized clinical trial", Neurology, 55, pp.236~242 (2000)
20. Chadwick DW, "Valproate monotherapy in the management of generalized and partial seizures", Epilepsia, 28(Suppl 2), pp.S12~S17 (1987)
21. Chen D, "A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with refractory epilepsy", Neuropsychiatr Dis Treat, 15, pp.905~917 (2019)
22. Montenegro MA, "Efficacy of clobazam as add-on therapy in patients with refractory partial epilepsy", Epilepsia, 42, pp.539~542 (2001)
23. "Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5", Neurology, 43, pp.2292~2298 (1993)
24. Jozwiak S, "Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine-or valproate-resistant epilepsy", Seizure, 9, pp.486~492 (2000)
25. Steinhoff BJ, "The SKATE study : an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy", Epilepsy Res, 76, pp.6~14 (2007)
26. Barcs G, "Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy", Epilepsia, 41, pp.1597~1607 (2000)
27. Sun MZ, "Comparison of add-on valproate and primidone in carbamazepine-unresponsive patients with partial epilepsy", Seizure, 18, pp.90~93 (2009)
28. Jedrzejczak J, "Tiagabine as add-on therapy may be more effective with valproic acid--open label, multicentre study of patients with focal epilepsy", Eur J Neurol, 12, pp.176~180 (2005)
29. Krakow K, "Topiramate in add-on therapy : results from an open-label, observational study", Seizure, 16, pp.593~600 (2007)
30. Vossler DG, "Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: results from a multicenter, open-label trial", Epilepsia, 57, pp.1625~1633 (2016)
31. Shih JJ, "Epilepsy treatment in adults and adolescents : expert opinion, 2016", Epilepsy Behav, 69, pp.186~222 (2017)
32. von Rosenstiel P, "Brivaracetam(UCB 34714)", Neurotherapeutics, 4, pp.84~87 (2007)
33. Almeida L, "Eslicarbazepine acetate (BIA 2-093)", Neurotherapeutics, 4, pp.88~96 (2007)
34. French JA, "Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy", Neurology, 76, pp.1555~1563 (2011)
35. Marson AG, "The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial", Lancet, 369, pp.1016~1026 (2007)
36. National Clinical Guideline Centre, "The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care" (2012), Royal College of Physicians
37. Allen JW, "Clobazam as adjunctive treatment in refractory epilepsy", Br Med J(Clin Res Ed), 286, pp.1246~1247 (1983)
38. Kumar SP, "Levetiracetam as add-on therapy in generalised epilepsies", Seizure, 13, pp.475~477 (2004)
39. French JA, "Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy : a randomized trial", Neurology, 85, pp.950~957 (2015)
40. Glauser TA, "Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy", N Engl J Med, 362, pp.790~799 (2010)
41. Brigo F, "Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents", Cochrane Database Syst Rev, 2, pp.CD003032~ (2017)
42. Nevitt SJ, "Sodium valproate versus phenytoin monotherapy for epilepsy : an individual participant data review", Cochrane Database Syst Rev, 8, pp.CD001769~ (2018)
43. Dahlin MG, "Reduction of seizures with lowdose clonazepam in children with epilepsy", Pediatr Neurol, 28, pp.48~52 (2003)
44. Verrotti A, "Levetiracetam in absence epilepsy", Dev Med Child Neurol, 50, pp.850~853 (2008)
45. Kessler SK, "A practical guide to treatment of childhood absence epilepsy", Paediatr Drugs, 21, pp.15~24 (2019)
46. Noachtar S, "Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures", Neurology, 70, pp.607~616 (2008)
47. Machado RA, "Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults : a prospective, unblinded randomized controlled trial", Seizure, 22, pp.846~855 (2013)
48. Vossler DG, "Zonisamide for the treatment of myoclonic seizures in progressive myoclonic epilepsy : an open-label study", Epileptic Disord, 10, pp.31~34 (2008)
49. Motte J, "Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group", N Engl J Med, 337, pp.1807~1812 (1997)
50. Verrotti A, "The pharmacological management of Lennox-Gastaut syndrome and critical literature review", Seizure, 63, pp.17~25 (2018)
51. Balagura G, "Adjunctive rufinamide in children with Lennox-Gastaut syndrome : a literature review", Neuropsychiatr Dis Treat, 16, pp.369~379 (2020)
52. Bektaş G, "Aggravation of atonic seizures by rufinamide : a case report", Brain Dev, 38, pp.654~657 (2016)

관련 논문AI추천